Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1960 1
1961 1
1962 2
1963 3
1964 1
1965 3
1966 1
1967 1
1968 2
1969 2
1970 1
1971 3
1972 3
1973 4
1974 2
1975 2
1976 1
1978 3
1979 1
1980 4
1981 3
1982 2
1983 2
1984 3
1985 3
1986 3
1987 2
1988 4
1989 3
1990 4
1991 2
1993 1
1994 2
1995 2
1996 2
1997 3
1999 2
2000 1
2001 1
2002 4
2003 5
2004 3
2005 2
2006 3
2008 3
2009 7
2010 8
2011 3
2012 3
2013 2
2014 4
2015 3
2016 5
2017 2
2018 4
2019 10
2020 7
2021 2
2022 2
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Results by year

Filters applied: . Clear all
Page 1
A human breast atlas integrating single-cell proteomics and transcriptomics.
Gray GK, Li CM, Rosenbluth JM, Selfors LM, Girnius N, Lin JR, Schackmann RCJ, Goh WL, Moore K, Shapiro HK, Mei S, D'Andrea K, Nathanson KL, Sorger PK, Santagata S, Regev A, Garber JE, Dillon DA, Brugge JS. Gray GK, et al. Among authors: rosenbluth jm. Dev Cell. 2022 Jun 6;57(11):1400-1420.e7. doi: 10.1016/j.devcel.2022.05.003. Epub 2022 May 25. Dev Cell. 2022. PMID: 35617956 Free PMC article.
Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma.
Morschhauser F, Fowler NH, Feugier P, Bouabdallah R, Tilly H, Palomba ML, Fruchart C, Libby EN, Casasnovas RO, Flinn IW, Haioun C, Maisonneuve H, Ysebaert L, Bartlett NL, Bouabdallah K, Brice P, Ribrag V, Daguindau N, Le Gouill S, Pica GM, Martin Garcia-Sancho A, López-Guillermo A, Larouche JF, Ando K, Gomes da Silva M, André M, Zachée P, Sehn LH, Tobinai K, Cartron G, Liu D, Wang J, Xerri L, Salles GA; RELEVANCE Trial Investigators. Morschhauser F, et al. N Engl J Med. 2018 Sep 6;379(10):934-947. doi: 10.1056/NEJMoa1805104. N Engl J Med. 2018. PMID: 30184451 Free PMC article. Clinical Trial.
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial.
Richardson PG, Oriol A, Beksac M, Liberati AM, Galli M, Schjesvold F, Lindsay J, Weisel K, White D, Facon T, San Miguel J, Sunami K, O'Gorman P, Sonneveld P, Robak P, Semochkin S, Schey S, Yu X, Doerr T, Bensmaine A, Biyukov T, Peluso T, Zaki M, Anderson K, Dimopoulos M; OPTIMISMM trial investigators. Richardson PG, et al. Lancet Oncol. 2019 Jun;20(6):781-794. doi: 10.1016/S1470-2045(19)30152-4. Epub 2019 May 13. Lancet Oncol. 2019. PMID: 31097405 Clinical Trial.
A large peptidome dataset improves HLA class I epitope prediction across most of the human population.
Sarkizova S, Klaeger S, Le PM, Li LW, Oliveira G, Keshishian H, Hartigan CR, Zhang W, Braun DA, Ligon KL, Bachireddy P, Zervantonakis IK, Rosenbluth JM, Ouspenskaia T, Law T, Justesen S, Stevens J, Lane WJ, Eisenhaure T, Lan Zhang G, Clauser KR, Hacohen N, Carr SA, Wu CJ, Keskin DB. Sarkizova S, et al. Among authors: rosenbluth jm. Nat Biotechnol. 2020 Feb;38(2):199-209. doi: 10.1038/s41587-019-0322-9. Epub 2019 Dec 16. Nat Biotechnol. 2020. PMID: 31844290 Free PMC article.
Inflammatory Breast Cancer: a Separate Entity.
Rosenbluth JM, Overmoyer BA. Rosenbluth JM, et al. Curr Oncol Rep. 2019 Aug 15;21(10):86. doi: 10.1007/s11912-019-0842-y. Curr Oncol Rep. 2019. PMID: 31414257 Review.
Decision-support tools to build climate resilience against emerging infectious diseases in Europe and beyond.
Rocklöv J, Semenza JC, Dasgupta S, Robinson EJZ, Abd El Wahed A, Alcayna T, Arnés-Sanz C, Bailey M, Bärnighausen T, Bartumeus F, Borrell C, Bouwer LM, Bretonnière PA, Bunker A, Chavardes C, van Daalen KR, Encarnação J, González-Reviriego N, Guo J, Johnson K, Koopmans MPG, Máñez Costa M, Michaelakis A, Montalvo T, Omazic A, Palmer JRB, Preet R, Romanello M, Shafiul Alam M, Sikkema RS, Terrado M, Treskova M, Urquiza D; IDAlert Consortium; Lowe R. Rocklöv J, et al. Lancet Reg Health Eur. 2023 Aug 7;32:100701. doi: 10.1016/j.lanepe.2023.100701. eCollection 2023 Sep. Lancet Reg Health Eur. 2023. PMID: 37583927 Free PMC article. Review.
Clinical outcomes of de novo metastatic HER2-positive inflammatory breast cancer.
Garrido-Castro AC, Regan MM, Niman SM, Nakhlis F, Remolano C, Rosenbluth JM, Block C, Warren LE, Bellon JR, Yeh E, Harrison BT, Troll E, Lin NU, Tolaney SM, Overmoyer B, Lynce F. Garrido-Castro AC, et al. Among authors: rosenbluth jm. NPJ Breast Cancer. 2023 Jun 2;9(1):50. doi: 10.1038/s41523-023-00555-w. NPJ Breast Cancer. 2023. PMID: 37268625 Free PMC article.
160 results